微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.81% | 54.25% | 11.08% | 37/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 3.43% | 167.97% | 17.06% | 13/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 2.93% | 127.85% | -24.68% | 68/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 3.89% | 164.19% | 57.49% | 64/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 2.47% | 302.46% | 92.97% | 64/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 1.28% | 390.91% | 112.17% | 63/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -10.52% | -6.37% | -73.6% | 123/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -6.06% | -1578.05% | -396.72% | 124/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -1.22% | -216.19% | -177.27% | 116/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.44% | -125.58% | 95.55% | 113/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -9.89% | 55.57% | -2512.2% | 124/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 0.41% | 106.86% | -60.95% | 109/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.05% | 126.38% | -38.95% | 102/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.72% | 144.79% | 107.73% | 70/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | -22.26% | -9778.26% | -272.24% | 127/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | -5.98% | -279.04% | -50.25% | 114/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | -3.98% | -153.78% | -3.65% | 121/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | -3.84% | -218.15% | -1769.57% | 111/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 0.23% | -98.56% | -93.11% | 121/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.34% | -84.89% | -54.86% | 100/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 7.4% | -34.57% | 127.69% | 55/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 3.25% | 150% | -79.71% | 52/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 16.02% | 5240% | -27.51% | 62/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 22.1% | 692.11% | 95.4% | 24/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 11.31% | 1200% | 770% | 41/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.3% | 136.36% | 333.33% | 53/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 0.3% | 101.8% | -89.25% | 109/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 2.79% | 76.58% | 220.69% | 57/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 0.87% | 11.54% | 58.18% | 68/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.55% | 52.78% | 103.3% | 49/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | -16.67% | -5002.94% | -1155.06% | 111/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 1.58% | 0% | 102.56% | 53/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 0.78% | -12.36% | 116.67% | 54/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 0.36% | -42.86% | 5.88% | 49/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 0.34% | -84.75% | -78.48% | 95/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 1.58% | -31.9% | 77.53% | 44/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 0.89% | -23.93% | 41.27% | 53/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 0.63% | -19.23% | -71.75% | 40/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 2.23% | -47.78% | -3.88% | 74/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 2.32% | -30.54% | 98.29% | 36/141 | 8.86% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 1.17% | -42.36% | 50% | 47/141 | 6.35% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 0.78% | -7.14% | -81.73% | 29/141 | 2.3% | 健帆生物 | 7.75% | 行业排名> |